Yeshwanth Vedire

Roswell Park Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer”.

Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer

Scientific Reports(2023)10.1038/s41598-023-34690-y

N/A

0.360DataRank · unranked

10 citations

Sarbajit Mukherjee, Sumedha Dondapati, Sai Yendamuri, Yeshwanth Vedire

Glucagon-like peptide-1 receptor agonism improves lung cancer outcomes and tumor growth control

JCI Insight(2025)10.1172/jci.insight.195484

N/A

0.292DataRank · unranked

6 citations

Bailey G. Fitzgerald, Joyce Ogidigo, Meera Bhatia, Randall J. Smith, Kalyan Ratnakaram +10 more

Robust eIF4B levels undermine invasive growth and immune evasion mechanisms in murine triple negative breast cancer models

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.16.508318

N/A

0.104DataRank · unranked

1 citations

Leila Zabihi Diba, Aravind Srinivasan, Robert Zollo, Thomas Ossevoort, Qian He +15 more

Obesity and lung cancer—a narrative review

Journal of Thoracic Disease(2023)10.21037/jtd-22-1835

N/A

0DataRank · unranked

34 citations

Sukumar Kalvapudi, Sai Yendamuri, Yeshwanth Vedire

Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

Frontiers in Oncology(2023)10.3389/fonc.2023.1286104

N/A

0DataRank · unranked

22 citations

Yeshwanth Vedire, Sai Yendamuri, Joseph Barbi, Sukumar Kalvapudi